Kamalakannan Vijayan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kamalakannan Vijayan has a total of 126 co-authors. Here are the top co-authors by number of shared publications:
- Alexis Kaushansky
Center for Global Infectious Disease Research, Seattle Children’s Research Institute, Seattle, WA, USA
10 shared publications - Rangarajan Badri Narayanan
Centre for Biotechnology, Anna University, Chennai, India
5 shared publications Heather S. Kain
Center for Infectious Disease Research, Seattle, WA, USA
4 shared publicationsAlan Aderem
Center for Infectious Disease Research, Seattle, WA, USA; Seattle Children's Research Institute, Seattle, WA, USA; Department of Pediatrics, University of Washington, Seattle, WA, USA
3 shared publicationsElizabeth K.K. Glennon
Seattle Children’s Research Institute, Seattle, Washington
3 shared publicationsJohn D. Aitchison
Center for Infectious Disease Research, Seattle, WA, USA; Seattle Children's Research Institute, Seattle, WA, USA; Department of Biochemistry, University of Washington, Seattle, WA, USA; Department of Pediatrics, University of Washington, Seattle, WA, USA
3 shared publications
Latest Publications
- Open Access
- 14 September 2026
- Published by Elsevier in SSRN Electronic Journal
A Comparative Chemical-Genetic Screen Reveals Divergent Roles for Host ALK2 Signaling Across Intracellular Bacterial Niches
Diverse vacuolar architectures present unique signaling challenges for intracellular bacteria, yet whether distinct niches share host requirements remains unclear. Because host kinases coordinate these complex cellular responses, we performed a comparative chemical-genetic screen of Coxiella burnetii, Chlamydia trachomatis, and Salmonella enterica. The screen revealed that C. burnetii is uniquely dependent on host kinase pathways. Deconvolution of these inhibitor profiles identified the bone morphogenetic protein (BMP) type I receptor, ALK2, as a critical regulatory checkpoint. While C. burnetii activates ALK2-mediated phospho-SMAD1/5/9 signaling to support replication, C. trachomatis actively suppresses this cascade. Mechanistically, ALK2 functions upstream of TFEB nuclear translocation and LAMP1 recruitment, driving the lysosomal biogenesis required to sustain the phagolysosome-like niche of C. burnetii while disrupting the non-lysosomal inclusion of C. trachomatis. Consequently, targeting ALK2 switches replication outcomes, demonstrating how distinct niches implement opposing strategies to exploit a single host signaling node.
- 14 September 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessA Comparative Chemical-Genetic Screen Reveals Divergent Roles for Host ALK2 Signaling Across Intracellular Bacterial Niches
Diverse vacuolar architectures present unique signaling challenges for intracellular bacteria, yet whether distinct niches share host requirements remains unclear. Because host kinases coordinate these complex cellular responses, we performed a comparative chemical-genetic screen of Coxiella burnetii, Chlamydia trachomatis, and Salmonella enterica. The screen revealed that C. burnetii is uniquely dependent on host kinase pathways. Deconvolution of these inhibitor profiles identified the bone morphogenetic protein (BMP) type I receptor, ALK2, as a critical regulatory checkpoint. While C. burnetii activates ALK2-mediated phospho-SMAD1/5/9 signaling to support replication, C. trachomatis actively suppresses this cascade. Mechanistically, ALK2 functions upstream of TFEB nuclear translocation and LAMP1 recruitment, driving the lysosomal biogenesis required to sustain the phagolysosome-like niche of C. burnetii while disrupting the non-lysosomal inclusion of C. trachomatis. Consequently, targeting ALK2 switches replication outcomes, demonstrating how distinct niches implement opposing strategies to exploit a single host signaling node.
- Open Access
Genome-scale prediction of context-specific synthetic lethality beyond protein interaction networks
Identifying synthetic lethal (SL) interactions offers a principled framework for discovering disease-specific therapeutic targets. However, current machine learning approaches heavily rely on curated protein-protein interaction networks. Because these networks cover only ∼7,500 proteins, they severely restrict the search space of human gene pairs and introduce systematic biases toward well-characterized genes. To circumvent these limitations, we developed SLxGO, a network-independent machine learning framework that predicts SL interactions directly from semantic representations of Gene Ontology annotations encoded via BioBERT-derived embeddings. Benchmarked across multiple cross-validation schemes against eight state-of-the-art methods, SLxGO consistently achieved superior predictive ranking performance, maintaining robustness under cold-start conditions for previously unseen genes. Integrating cell line-specific transcriptional profiles extended this framework to context-dependent SL prediction across six distinct cell lines. Notably, we experimentally confirmed a context-specific EFNA1 - SLC29A1 SL interaction in HeLa cells, alongside synergistic pharmacological validation of an ACVR1 - SLC29A1 vulnerability. All predictions are hosted on SLiGO, an open-access database encompassing 30 million human gene pairs, establishing a comprehensive, genome-scale resource for context-specific vulnerability mapping across the human interactome.
Open AccessGenome-scale prediction of context-specific synthetic lethality beyond protein interaction networks
Identifying synthetic lethal (SL) interactions offers a principled framework for discovering disease-specific therapeutic targets. However, current machine learning approaches heavily rely on curated protein-protein interaction networks. Because these networks cover only ∼7,500 proteins, they severely restrict the search space of human gene pairs and introduce systematic biases toward well-characterized genes. To circumvent these limitations, we developed SLxGO, a network-independent machine learning framework that predicts SL interactions directly from semantic representations of Gene Ontology annotations encoded via BioBERT-derived embeddings. Benchmarked across multiple cross-validation schemes against eight state-of-the-art methods, SLxGO consistently achieved superior predictive ranking performance, maintaining robustness under cold-start conditions for previously unseen genes. Integrating cell line-specific transcriptional profiles extended this framework to context-dependent SL prediction across six distinct cell lines. Notably, we experimentally confirmed a context-specific EFNA1 - SLC29A1 SL interaction in HeLa cells, alongside synergistic pharmacological validation of an ACVR1 - SLC29A1 vulnerability. All predictions are hosted on SLiGO, an open-access database encompassing 30 million human gene pairs, establishing a comprehensive, genome-scale resource for context-specific vulnerability mapping across the human interactome.
- Open Access
A Comparative Chemical-Genetic Screen Reveals Divergent Roles for Host ALK2 Signaling Across Intracellular Bacterial Niches
Diverse vacuolar architectures present unique signaling challenges for intracellular bacteria, yet whether distinct niches share host requirements remains unclear. Because host kinases coordinate these complex cellular responses, we performed a comparative chemical-genetic screen of Coxiella burnetii , Chlamydia trachomatis , and Salmonella enterica . The screen revealed that C. burnetii is uniquely dependent on host kinase pathways. Deconvolution of these inhibitor profiles identified the bone morphogenetic protein (BMP) type I receptor, ALK2, as a critical regulatory checkpoint. While C. burnetii activates ALK2-mediated phospho-SMAD1/5/9 signaling to support replication, C. trachomatis actively suppresses this cascade. Mechanistically, ALK2 functions upstream of TFEB nuclear translocation and LAMP1 recruitment, driving the lysosomal biogenesis required to sustain the phagolysosome-like niche of C. burnetii while disrupting the non-lysosomal inclusion of C. trachomatis . Consequently, targeting ALK2 switches replication outcomes, demonstrating how distinct niches implement opposing strategies to exploit a single host signaling node.
Open AccessA Comparative Chemical-Genetic Screen Reveals Divergent Roles for Host ALK2 Signaling Across Intracellular Bacterial Niches
Diverse vacuolar architectures present unique signaling challenges for intracellular bacteria, yet whether distinct niches share host requirements remains unclear. Because host kinases coordinate these complex cellular responses, we performed a comparative chemical-genetic screen of Coxiella burnetii , Chlamydia trachomatis , and Salmonella enterica . The screen revealed that C. burnetii is uniquely dependent on host kinase pathways. Deconvolution of these inhibitor profiles identified the bone morphogenetic protein (BMP) type I receptor, ALK2, as a critical regulatory checkpoint. While C. burnetii activates ALK2-mediated phospho-SMAD1/5/9 signaling to support replication, C. trachomatis actively suppresses this cascade. Mechanistically, ALK2 functions upstream of TFEB nuclear translocation and LAMP1 recruitment, driving the lysosomal biogenesis required to sustain the phagolysosome-like niche of C. burnetii while disrupting the non-lysosomal inclusion of C. trachomatis . Consequently, targeting ALK2 switches replication outcomes, demonstrating how distinct niches implement opposing strategies to exploit a single host signaling node.
- Open Access
- 16 June 2026
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 234 (4) , e940-e951
Host Reticulocyte Redox Attenuation Creates a Protective Niche for Artemisinin Tolerance in Plasmodium falciparum
Background: Artemisinin-based combination therapies are the cornerstone of Plasmodium falciparum malaria treatment; however, delayed parasite clearance and treatment failure occur even in the absence of established parasite genetic resistance. While parasite-intrinsic resistance mechanisms have been extensively studied, the contribution of host erythroid heterogeneity to antimalarial drug response remains poorly defined. Methods: Highly purified human CD71+ reticulocytes and mature erythrocytes were used to assess parasite invasion, intraerythrocytic development, and drug susceptibility. Integrated metabolomic and proteomic analyses characterized host cell environments. Parasite responses to artemisinin derivatives and antimalarials with distinct mechanisms of action were systematically evaluated. Results: P. falciparum preferentially invaded reticulocytes and exhibited accelerated asexual development within these cells. Multiomics analyses demonstrated that reticulocytes provide a metabolically enriched, antioxidant-modulated intracellular environment, marked by increased nucleotide precursors, enhanced glutathione metabolism, and elevated levels of reactive oxygen species-detoxifying enzymes. Parasites developing within reticulocytes showed significantly reduced susceptibility to artemisinin and dihydroartemisinin, as well as to other redox-active antimalarials, while maintaining comparable sensitivity to drugs with nonoxidative mechanisms. Reticulocyte-resident parasites also demonstrated enhanced survival and recrudescence following artemisinin exposure. Conclusions: Erythroid maturation state is a key host determinant of antimalarial drug efficacy. Reticulocytes form a redox-protected intracellular niche that attenuates drug-induced oxidative stress and promotes parasite persistence, consistent with a host cell-mediated tolerance phenotype. These findings provide a mechanistic framework for variability in treatment outcomes associated with reticulocytosis and anemia.
- 16 June 2026
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 234 (4) , e940-e951
Open AccessHost Reticulocyte Redox Attenuation Creates a Protective Niche for Artemisinin Tolerance in Plasmodium falciparum
Background: Artemisinin-based combination therapies are the cornerstone of Plasmodium falciparum malaria treatment; however, delayed parasite clearance and treatment failure occur even in the absence of established parasite genetic resistance. While parasite-intrinsic resistance mechanisms have been extensively studied, the contribution of host erythroid heterogeneity to antimalarial drug response remains poorly defined. Methods: Highly purified human CD71+ reticulocytes and mature erythrocytes were used to assess parasite invasion, intraerythrocytic development, and drug susceptibility. Integrated metabolomic and proteomic analyses characterized host cell environments. Parasite responses to artemisinin derivatives and antimalarials with distinct mechanisms of action were systematically evaluated. Results: P. falciparum preferentially invaded reticulocytes and exhibited accelerated asexual development within these cells. Multiomics analyses demonstrated that reticulocytes provide a metabolically enriched, antioxidant-modulated intracellular environment, marked by increased nucleotide precursors, enhanced glutathione metabolism, and elevated levels of reactive oxygen species-detoxifying enzymes. Parasites developing within reticulocytes showed significantly reduced susceptibility to artemisinin and dihydroartemisinin, as well as to other redox-active antimalarials, while maintaining comparable sensitivity to drugs with nonoxidative mechanisms. Reticulocyte-resident parasites also demonstrated enhanced survival and recrudescence following artemisinin exposure. Conclusions: Erythroid maturation state is a key host determinant of antimalarial drug efficacy. Reticulocytes form a redox-protected intracellular niche that attenuates drug-induced oxidative stress and promotes parasite persistence, consistent with a host cell-mediated tolerance phenotype. These findings provide a mechanistic framework for variability in treatment outcomes associated with reticulocytosis and anemia.
- 5 November 2024
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 10 (12) , 4040-4047
Apicomplexan Espionage: Orchestrated Miscommunication at the Host–Parasite Interface
Intracellular parasites, including Toxoplasma and Plasmodium, are entirely reliant on the active scavenging of host-derived nutrients to fuel their replicative cycle, as they are confined within a specialized membrane-bound compartment, the parasitophorous vacuole (PV). Initial observations, based on the proximity of host vesicles to the parasitophorous vacuole membrane (PVM), suggested that parasites utilize host vesicles to obtain essential nutrients. However, mounting evidence has now unequivocally demonstrated that intracellular pathogens establish membrane contacts with host organelles, establishing control over host cellular machinery. These intimate interactions enable the parasites to gain unimpeded access to cytosolic resources critical for development while evading host immune responses. This review consolidates the latest advancements in understanding the molecular machinery driving these transkingdom contacts and their functional roles. Further investigation into these processes promises to revolutionize our understanding of organelle communication, with profound implications for identifying new therapeutic targets and strategies.
- 5 November 2024
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 10 (12) , 4040-4047
Apicomplexan Espionage: Orchestrated Miscommunication at the Host–Parasite Interface
Intracellular parasites, including Toxoplasma and Plasmodium, are entirely reliant on the active scavenging of host-derived nutrients to fuel their replicative cycle, as they are confined within a specialized membrane-bound compartment, the parasitophorous vacuole (PV). Initial observations, based on the proximity of host vesicles to the parasitophorous vacuole membrane (PVM), suggested that parasites utilize host vesicles to obtain essential nutrients. However, mounting evidence has now unequivocally demonstrated that intracellular pathogens establish membrane contacts with host organelles, establishing control over host cellular machinery. These intimate interactions enable the parasites to gain unimpeded access to cytosolic resources critical for development while evading host immune responses. This review consolidates the latest advancements in understanding the molecular machinery driving these transkingdom contacts and their functional roles. Further investigation into these processes promises to revolutionize our understanding of organelle communication, with profound implications for identifying new therapeutic targets and strategies.
- 2 August 2024
- Published by Wiley in The FASEB Journal
- Vol. 38 (15) , e23856
NDV targets the invasion pathway in malaria parasite through cell surface sialic acid interaction
Merozoites utilize sialic acids on the red blood cell (RBC) cell surface to rapidly adhere to and invade the RBCs. Newcastle disease virus (NDV) displays a strong affinity toward membrane‐bound sialic acids. Incubation of NDV with the malaria parasites dose‐dependently reduces its cellular viability. The antiplasmodial activity of NDV is specific, as incubation with Japanese encephalitis virus, duck enteritis virus, infectious bronchitis virus, and influenza virus did not affect the parasite propagation. Interestingly, NDV is reducing more than 80% invasion when RBCs are pretreated with the virus. Removal of the RBC surface proteins or the NDV coat proteins results in disruption of the virus binding to RBC. It suggests the involvement of specific protein: ligand interaction in virus binding. We established that the virus engages with the parasitized RBCs (PRBCs) through its hemagglutinin neuraminidase (HN) protein by recognizing sialic acid‐containing glycoproteins on the cell surface. Blocking of the HN protein with free sialic acid or anti‐HN antibodies abolished the virus binding as well as its ability to reduce parasite growth. Interestingly, the purified HN from the virus alone could inhibit the parasite's growth in a dose‐dependent manner. NDV binds strongly to knobless murine parasite strain Plasmodium yoelii and restricted the parasite growth in mice. Furthermore, the virus was found to preferentially target the PRBCs compared to normal erythrocytes. Immunolocalization studies reveal that NDV is localized on the plasma membrane as well as weakly inside the PRBC. NDV causes neither any infection nor aggregation of the human RBCs. Our findings suggest that NDV is a potential candidate for developing targeted drug delivery platforms for the Plasmodium ‐infected RBCs.
- 2 August 2024
- Published by Wiley in The FASEB Journal
- Vol. 38 (15) , e23856
NDV targets the invasion pathway in malaria parasite through cell surface sialic acid interaction
Merozoites utilize sialic acids on the red blood cell (RBC) cell surface to rapidly adhere to and invade the RBCs. Newcastle disease virus (NDV) displays a strong affinity toward membrane‐bound sialic acids. Incubation of NDV with the malaria parasites dose‐dependently reduces its cellular viability. The antiplasmodial activity of NDV is specific, as incubation with Japanese encephalitis virus, duck enteritis virus, infectious bronchitis virus, and influenza virus did not affect the parasite propagation. Interestingly, NDV is reducing more than 80% invasion when RBCs are pretreated with the virus. Removal of the RBC surface proteins or the NDV coat proteins results in disruption of the virus binding to RBC. It suggests the involvement of specific protein: ligand interaction in virus binding. We established that the virus engages with the parasitized RBCs (PRBCs) through its hemagglutinin neuraminidase (HN) protein by recognizing sialic acid‐containing glycoproteins on the cell surface. Blocking of the HN protein with free sialic acid or anti‐HN antibodies abolished the virus binding as well as its ability to reduce parasite growth. Interestingly, the purified HN from the virus alone could inhibit the parasite's growth in a dose‐dependent manner. NDV binds strongly to knobless murine parasite strain Plasmodium yoelii and restricted the parasite growth in mice. Furthermore, the virus was found to preferentially target the PRBCs compared to normal erythrocytes. Immunolocalization studies reveal that NDV is localized on the plasma membrane as well as weakly inside the PRBC. NDV causes neither any infection nor aggregation of the human RBCs. Our findings suggest that NDV is a potential candidate for developing targeted drug delivery platforms for the Plasmodium ‐infected RBCs.
- Open Access
- 11 March 2024
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 7 (5) , e202302522
Interrogating endothelial barrier regulation by temporally resolved kinase network generation
Kinases are key players in endothelial barrier regulation, yet their temporal function and regulatory phosphosignaling networks are incompletely understood. We developed a novel methodology, Temporally REsolved KInase Network Generation (TREKING), which combines a 28-kinase inhibitor screen with machine learning and network reconstruction to build time-resolved, functional phosphosignaling networks. We demonstrated the utility of TREKING for identifying pathways mediating barrier integrity after activation by thrombin with or without TNF preconditioning in brain endothelial cells. TREKING predicted over 100 kinases involved in barrier regulation and discerned complex condition-specific pathways. For instance, the MAPK-activated protein kinase 2 (MAPKAPK2/MK2) had early barrier-weakening activity in both inflammatory conditions but late barrier-strengthening activity exclusively with thrombin alone. Using temporal Western blotting, we confirmed that MAPKAPK2/MK2 was differentially phosphorylated under the two inflammatory conditions. We further showed with lentivirus-mediated knockdown of MAPK14/p38α and drug targeting the MAPK14/p38α-MAPKAPK2/MK2 complex that a MAP3K20/ZAK-MAPK14/p38α axis controlled the late activation of MAPKAPK2/MK2 in the thrombin-alone condition. Beyond the MAPKAPK2/MK2 switch, TREKING predicts extensive interconnected networks that control endothelial barrier dynamics.
- 11 March 2024
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 7 (5) , e202302522
Open AccessInterrogating endothelial barrier regulation by temporally resolved kinase network generation
Kinases are key players in endothelial barrier regulation, yet their temporal function and regulatory phosphosignaling networks are incompletely understood. We developed a novel methodology, Temporally REsolved KInase Network Generation (TREKING), which combines a 28-kinase inhibitor screen with machine learning and network reconstruction to build time-resolved, functional phosphosignaling networks. We demonstrated the utility of TREKING for identifying pathways mediating barrier integrity after activation by thrombin with or without TNF preconditioning in brain endothelial cells. TREKING predicted over 100 kinases involved in barrier regulation and discerned complex condition-specific pathways. For instance, the MAPK-activated protein kinase 2 (MAPKAPK2/MK2) had early barrier-weakening activity in both inflammatory conditions but late barrier-strengthening activity exclusively with thrombin alone. Using temporal Western blotting, we confirmed that MAPKAPK2/MK2 was differentially phosphorylated under the two inflammatory conditions. We further showed with lentivirus-mediated knockdown of MAPK14/p38α and drug targeting the MAPK14/p38α-MAPKAPK2/MK2 complex that a MAP3K20/ZAK-MAPK14/p38α axis controlled the late activation of MAPKAPK2/MK2 in the thrombin-alone condition. Beyond the MAPKAPK2/MK2 switch, TREKING predicts extensive interconnected networks that control endothelial barrier dynamics.
- Open Access
- 20 September 2023
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 13, 1288638
Editorial: Advancing the understanding of key events in the intracellular parasitism by apicomplexan parasites
Editorial: Advancing the understanding of key events in the intracellular parasitism by apicomplexan parasites
- 20 September 2023
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 13, 1288638
Open AccessEditorial: Advancing the understanding of key events in the intracellular parasitism by apicomplexan parasites
Editorial: Advancing the understanding of key events in the intracellular parasitism by apicomplexan parasites
- Open Access
Interrogating endothelial barrier regulation by temporally resolved kinase network generation
Vascular leak is a common disease complication, yet the signaling networks regulating barrier integrity are incompletely understood. We developed a novel methodology, Temporally REsolved KInase Network Generation (TREKING), which combines a 28-kinase inhibitor screen with machine learning and network reconstruction to build time-resolved, functional phosphosignaling networks. We demonstrated the utility of TREKING for identifying pathways mediating barrier integrity following thrombin stimulation with or without tumor necrosis factor (TNF) activation in brain endothelial cells. TREKING assigned distinct barrier phenotypes to mitogen-activated protein kinase (MAPK) pathways and revealed a condition-specific MAPKAPK2/MK2 switch kinase pathway with early barrier-disruptive activity in both inflammatory conditions, but late barrier-restorative activity exclusively in the absence of TNF pre-conditioning. MAPKAPK2/MK2 was activated with expected distinct kinetics under the two inflammatory conditions and late activation was linked to a MAP3K20/ZAK-MAPK14/p38α-MAPKAPK2/MK2 pathway. Beyond MAPKs, TREKING predicts extensive interconnected networks that control barrier integrity and is a tool for dissecting complex temporal phosphosignaling networks across biological systems.
Open AccessInterrogating endothelial barrier regulation by temporally resolved kinase network generation
Vascular leak is a common disease complication, yet the signaling networks regulating barrier integrity are incompletely understood. We developed a novel methodology, Temporally REsolved KInase Network Generation (TREKING), which combines a 28-kinase inhibitor screen with machine learning and network reconstruction to build time-resolved, functional phosphosignaling networks. We demonstrated the utility of TREKING for identifying pathways mediating barrier integrity following thrombin stimulation with or without tumor necrosis factor (TNF) activation in brain endothelial cells. TREKING assigned distinct barrier phenotypes to mitogen-activated protein kinase (MAPK) pathways and revealed a condition-specific MAPKAPK2/MK2 switch kinase pathway with early barrier-disruptive activity in both inflammatory conditions, but late barrier-restorative activity exclusively in the absence of TNF pre-conditioning. MAPKAPK2/MK2 was activated with expected distinct kinetics under the two inflammatory conditions and late activation was linked to a MAP3K20/ZAK-MAPK14/p38α-MAPKAPK2/MK2 pathway. Beyond MAPKs, TREKING predicts extensive interconnected networks that control barrier integrity and is a tool for dissecting complex temporal phosphosignaling networks across biological systems.
- 22 June 2022
- Published by Elsevier in Cell Chemical Biology
- Vol. 29 (9) , 1419-1433.e5
A genome-wide CRISPR-Cas9 screen identifies CENPJ as a host regulator of altered microtubule organization during Plasmodium liver infection
- 22 June 2022
- Published by Elsevier in Cell Chemical Biology
- Vol. 29 (9) , 1419-1433.e5
A genome-wide CRISPR-Cas9 screen identifies CENPJ as a host regulator of altered microtubule organization during Plasmodium liver infection